Evidence-based guideline update: Medical treatment of infantile spasms
Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received January 10, 2012
- Accepted March 19, 2012
- First Published June 11, 2012.
Author Disclosures
- C.Y. Go, MD,
- M.T. Mackay, MBBS, FRACP,
- S.K. Weiss, MD, FRCPC,
- D. Stephens, MSc,
- T. Adams-Webber, MLS,
- S. Ashwal, MD, FAAN and
- O.C. Snead III, MD FAAN
- C.Y. Go, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- M.T. Mackay, MBBS, FRACP,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- S.K. Weiss, MD, FRCPC,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- D. Stephens, MSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- T. Adams-Webber, MLS,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- S. Ashwal, MD, FAAN and
SITT trial DSMB member
NONE
NONE
PEDIATRIC NEUROLOGY
NONE
PEDIATRIC NEUROLOGY (JOURNAL) PEDIATRIAC NEUROLOGY:PRINICPLES AND PRACTICE; -- COEDITOR
NONE
NONE
NONE
NONE
NONE
NONE
Ongoing Research Support (OSR# 56232) S. Ashwal (PI) 2006- 2011 NIH-04-298 Phase II Multi-Center Study of Rapamycin for Treating Kidney Angiomyolipomas in TSC or LAM Patients. This study investigates the use of Rapamycin for the treatment of kidney angiomyolipomas in patients with tuberous sclerosis or lymphangioleiomyomatosis. Role: Principal Investigator (OSR# 56077) S. Ashwal (PI) 2006- 2011 NINDS--R01 NS054001-01 Pediatric TBI and DAI: Normal Appearing Brain is not Normal This prospective 5-yr study will use SWI, MRI and MRS in 90 pediatric TBI and 90 controls to determine which specific imaging variables will predict outcome. Role: Principal Investigator
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- O.C. Snead III, MD FAAN
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Hospital for Sick Children and University of Toronto. Faculty of Medicine (C.Y.G., S.K.W., D.S., T.A.-W., O.C.S.), Toronto, Canada; Royal Children's Hospital (M.T.M.), Melbourne, Australia; and Loma Linda University School of Medicine (S.A.), Loma Linda, CA.
- Correspondence & reprint requests to American Academy of Neurology: guidelines{at}aan.com
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.